SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
January 21, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its SYMJEPI® (epinephrine) Injection products are now available to members of the...
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
January 20, 2021 09:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the submission of an Investigational New Drug (IND) to FDA for the...
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
December 01, 2020 09:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a planned response to a Complete Response Letter (CRL) from the U.S. Food and Drug...
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
November 16, 2020 06:45 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that after the close of business and the U.S. markets on November 13th, it...
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
November 09, 2020 16:30 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2020 and provided a...
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business Update
November 05, 2020 09:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that it will host an investor conference call on Monday, November 9,...
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
September 18, 2020 09:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
September 17, 2020 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various...
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders
September 03, 2020 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the results of its reconvened 2020 annual meeting of stockholders which was initially...
Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders and Proposals
August 25, 2020 09:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided additional information concerning the proposals to be considered at its adjourned 2020...